Isotretinoin-Induced Delusional Disorder, Somatic Subtype

Joint Authors

Jensen, Katharine V.
Abba-Aji, Adam

Source

Case Reports in Dermatological Medicine

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-07-26

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Diseases

Abstract EN

Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne.

Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects.

Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusional disorder somatic subtype, in a young male in the absence of any prodromal symptoms, previous psychiatric history, or family history of mental illness.

The onset of psychosis was in the context of a dosage increase from 40 mg/day to 80 mg/day.

Isotretinoin was discontinued, and the patient showed improvement on low-dose quetiapine.

American Psychological Association (APA)

Jensen, Katharine V.& Abba-Aji, Adam. 2020. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1146904

Modern Language Association (MLA)

Jensen, Katharine V.& Abba-Aji, Adam. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1146904

American Medical Association (AMA)

Jensen, Katharine V.& Abba-Aji, Adam. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1146904

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1146904